Loading stock data…
SIGA Technologies Inc. (SIGA)
$3.20-0.09 (-2.74%)
Market ClosedLast close Sep 8
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
SIGA Technologies, Inc. in the Healthcare sector is trading at $3.20 with a market capitalization of $230M. The stock is currently near its 52-week low of $2.83, remaining 30.9% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $41.00M↑ | $6.24M↑ | $3.79M↑ | $2.62M↓ | $81.12M |
| Gross Profit | $23.44M↑ | $3.30M↑ | $804,474↓ | $1.62M↓ | $55.57M |
| Operating Income | $13.91M↑ | -$5.32M↑ | -$9.50M↑ | -$10.22M↓ | $45.68M |
| Net Income | $12.46M↑ | -$3.45M↑ | -$5.43M↑ | -$6.37M↓ | $35.48M |
Peer Comparison
JNJUNHPFE
Fundamentals
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$229.92M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.89
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-1.69%
Volume
Today's trading volume
785,383
Recent News
SIGA Tech (SIGA): Profits Drop 65%, But Cash and Special Payouts Remain
On August 6, SIGA Technologies (NASDAQ:SIGA) reported financial results for the three and six months ended June 30, and the numbers tell two very different stories depending on which quarter you compare them to. Revenue and profit both cratered from a year ago, yet the company still turned a profit, paid out a special dividend, […]
SIGA (SIGA) Q2 2026 Earnings Call Transcript
Revenue fell 49% year-over-year as government contract deliveries slowed.
SIGA Technologies, Inc. Q2 2026 Earnings Call Summary
Moby summary of SIGA Technologies, Inc.'s Q2 2026 earnings call
Siga Technologies Q2 Earnings Call Highlights
Siga Technologies (NASDAQ:SIGA) reported second-quarter product-related revenue of $38 million, driven primarily by deliveries of intravenous TPOXX to the U.S. Strategic National Stockpile and oral TPOXX sales to international customers. The company said the quarter reflected the variable timing of
SIGA Technologies Inc (SIGA) (Q2 2026) Earnings Call Highlights: Strong Revenue and Strategic ...
SIGA reports $38 million in product revenues, driven by US stockpile deliveries and international growth, while navigating slower-than-expected US procurement timelines.